Anti-IL5RA/ CD125/ CDw125 monoclonal antibody

Anti-IL5RA/ CD125/ CDw125 antibody for FACS & in-vivo assay

Target products collectionGo to IL5RA/IL5RA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T90828-Ab-1/ GM-Tg-hg-T90828-Ab-2Anti-Human IL5RA monoclonal antibodyHuman
GM-Tg-rg-T90828-Ab-1/ GM-Tg-rg-T90828-Ab-2Anti-Rat IL5RA monoclonal antibodyRat
GM-Tg-mg-T90828-Ab-1/ GM-Tg-mg-T90828-Ab-2Anti-Mouse IL5RA monoclonal antibodyMouse
GM-Tg-cynog-T90828-Ab-1/ GM-Tg-cynog-T90828-Ab-2Anti-Cynomolgus/ Rhesus macaque IL5RA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T90828-Ab-1/ GM-Tg-felg-T90828-Ab-2Anti-Feline IL5RA monoclonal antibodyFeline
GM-Tg-cang-T90828-Ab-1/ GM-Tg-cang-T90828-Ab-2Anti-Canine IL5RA monoclonal antibodyCanine
GM-Tg-bovg-T90828-Ab-1/ GM-Tg-bovg-T90828-Ab-2Anti-Bovine IL5RA monoclonal antibodyBovine
GM-Tg-equg-T90828-Ab-1/ GM-Tg-equg-T90828-Ab-2Anti-Equine IL5RA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T90828-Ab-1/ GM-Tg-hg-T90828-Ab-2; GM-Tg-rg-T90828-Ab-1/ GM-Tg-rg-T90828-Ab-2;
GM-Tg-mg-T90828-Ab-1/ GM-Tg-mg-T90828-Ab-2; GM-Tg-cynog-T90828-Ab-1/ GM-Tg-cynog-T90828-Ab-2;
GM-Tg-felg-T90828-Ab-1/ GM-Tg-felg-T90828-Ab-2; GM-Tg-cang-T90828-Ab-1/ GM-Tg-cang-T90828-Ab-2;
GM-Tg-bovg-T90828-Ab-1/ GM-Tg-bovg-T90828-Ab-2; GM-Tg-equg-T90828-Ab-1/ GM-Tg-equg-T90828-Ab-2
Products NameAnti-IL5RA monoclonal antibody
Formatmab
Target NameIL5RA
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL5RA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-058Pre-Made Benralizumab biosimilar, Whole mAb, Anti-IL5RA Antibody: Anti-CD125/CDw125/HSIL5R3/IL5R therapeutic antibody
    Target AntigenProducts DevelopingMulti-species IL5RA/ CD125/ CDw125 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLP001668human IL5RA Lentivirus plasmid
    ORF Viral VectorvGMLP001668human IL5RA Lentivirus particle
    ORF Viral VectorpGMLPm004308mouse Il5ra Lentivirus plasmid
    ORF Viral VectorvGMLPm004308mouse Il5ra Lentivirus particle


    Target information

    Target IDGM-T90828
    Target NameIL5RA
    Gene ID3568,16192,114103,704649,476553,101099031,615848,100060212
    Gene Symbol and SynonymsCD125,CDw125,HSIL5R3,IL5R,IL5RA
    Uniprot AccessionQ01344
    Uniprot Entry NameIL5RA_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000091181
    Target ClassificationN/A

    The target: IL5RA, gene name: IL5RA, also named as CD125, CDw125, HSIL5R3, IL5R. The protein encoded by this gene is an interleukin 5 specific subunit of a heterodimeric cytokine receptor. The receptor is comprised of a ligand specific alpha subunit and a signal transducing beta subunit shared by the receptors for interleukin 3 (IL3), colony stimulating factor 2 (CSF2/GM-CSF), and interleukin 5 (IL5). The binding of this protein to IL5 depends on the beta subunit. The beta subunit is activated by the ligand binding, and is required for the biological activities of IL5. This protein has been found to interact with syndecan binding protein (syntenin), which is required for IL5 mediated activation of the transcription factor SOX4. Several alternatively spliced transcript variants encoding four distinct isoforms have been reported. [provided by RefSeq, Jul 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.